Our findings indicate that EIF4A3 expression is significantly higher in 18 cancers, including GBM, GBMLGG, LGG, CESC, LUAD, COAD, COADREAD, BRCA, ESCA, STES, STAD, UCEC, HNSC, LUSC, LIHC, READ, BLCA and CHOL (P < 0.05, cancer type abbreviations are shown in supplementary Table 5). This evidence concerns the gene EIF4A3 and cancer.